Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
1(11%)
Results Posted
50%(2 trials)
Terminated
2(22%)

Phase Distribution

Ph phase_3
2
22%
Ph phase_1
1
11%
Ph phase_2
2
22%
Ph not_applicable
4
44%

Phase Distribution

1

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
2(22.2%)
Phase 3Large-scale testing
2(22.2%)
N/ANon-phased studies
4(44.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(4)
Terminated(2)
Other(2)

Detailed Status

Completed4
Terminated2
unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (11.1%)
Phase 22 (22.2%)
Phase 32 (22.2%)
N/A4 (44.4%)

Trials by Status

terminated222%
completed444%
unknown222%
recruiting111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
OTHER
Total Trials
9